Business profile not generated.
Run python -m application.cli.business_profile run --market US --one NIVFW, then regenerate the site.
A filing-first public record from Lucide House.
Issue 000 | U.S. Pilot | US
NewGenIvf Group Ltd
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Business profile not generated.
Run python -m application.cli.business_profile run --market US --one NIVFW, then regenerate the site.
Only 0 quarterly periods available from Data Vault for this company.
quarterly periods are missing
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
20-F
USD
|
2024-12-31
20-F
USD
|
2024-04-03
20-F
USD
|
2024-04-03
20-F
USD
|
2024-04-03
20-F
USD
|
2023-12-31
20-F
USD
|
|---|---|---|---|---|---|---|
| Revenue | 23,708,371 | 371,666 | n/a | n/a | n/a | 5,136,153 |
| Operating Income | -10,726,461 | -1,160,495 | n/a | n/a | n/a | 42,242 |
| Net Income | 9,879,408 | -524,643 | n/a | n/a | n/a | 130,193 |
| Cash From Operations | -10,926,056 | -8,264,074 | n/a | n/a | n/a | -1,766,135 |
| Capex | -135,025 | -53,045 | n/a | n/a | n/a | -69,848 |
| Free Cash Flow | -11,061,081 | -8,317,119 | n/a | n/a | n/a | -1,835,983 |
| Cash And Equivalents | 758,621 | 457,740 | n/a | n/a | n/a | 54,104 |
| Accounts Receivable | 166,531 | 49,245 | n/a | n/a | n/a | 9,374 |
| Inventory | 335,360 | 80,813 | n/a | n/a | n/a | 126,264 |
| Total Current Assets | 7,383,571 | 3,172,745 | n/a | n/a | n/a | 1,201,456 |
| Total Assets | 32,722,769 | 3,577,744 | n/a | n/a | n/a | 1,647,460 |
| Total Current Liabilities | 2,366,351 | 2,720,354 | n/a | n/a | n/a | 1,122,456 |
| Total Liabilities | 6,736,076 | 5,059,501 | n/a | n/a | n/a | 1,241,435 |
| Shareholders Equity | 26,631,519 | -1,048,614 | n/a | n/a | n/a | 896,076 |
| Shares Outstanding | 240,622 | 1,138,519 | n/a | n/a | n/a | 698,123 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 3,250,020 | 743,323 | n/a | n/a | n/a | 615,135 |
| Weighted Avg Shares Basic | 46,009 | 358,108 | n/a | n/a | n/a | 615,135 |
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
Only 0 quarterly periods available from Data Vault for this company.
| Metric |
|---|
| Revenue |
| Operating Income |
| Net Income |
| Cash From Operations |
| Capex |
| Free Cash Flow |
| Cash And Equivalents |
| Total Current Assets |
| Total Liabilities |
| Shares Outstanding |
| Shares Outstanding Diluted |
| Weighted Avg Shares Diluted |
| Weighted Avg Shares Basic |
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 7,383,571USD | us-gaap:AssetsCurrent | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001981662/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001981662\companyfacts.json |
| Total Liabilities | 6,736,076USD | us-gaap:Liabilities | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001981662/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001981662\companyfacts.json |
| Cash | 758,621USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001981662/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001981662\companyfacts.json |
| Shares Outstanding | 240,622 | us-gaap:CommonStockSharesOutstanding | 2025-12-31 | 1.00 |
sec/companyfacts/cik=0001981662/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001981662\companyfacts.json |
| NCAV | 647,495USD | derived | 2025-12-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 2.69USD | derived | 2025-12-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 99.4% | derived | 2025-12-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-03-31; mary_accession=0001213900-26-037687; mary_cik=0001981662; gnni_supporting_filing_date=2026-03-31; internal_discount=0.993943; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.